TCF7 and melanoma: In the context of immune checkpoint blockade therapy, an increased frequency of less-differentiated memory T cells with higher expression of TCF-1 (encoded by Tcf7) in the tumor microenvironment was correlated with response to the treatment and better survival in preclinical models and human melanomas (11, 45, 46).